Skip to main content
TipRanks
Go Ultimate75% OFF

Amneal Pharmaceuticals (2DT) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

2DT Analyst Ratings

Strong Buy
6Ratings
6Buy0Hold0Sell
Based on 6 analysts giving stock ratings to Amneal Pharmaceuticals in the past 3 months

2DT Stock 12 Month Forecast

€22.53▲(16.72% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Amneal Pharmaceuticals in the last 3 months. The average price target is EUR 22.53 with a high forecast of EUR 25.40 and a low forecast of EUR 18.14. The average price target represents a 16.72% change from the last price of EUR 19.30.
Highest Price Target€25.40Average Price Target€22.53Lowest Price Target€18.14

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2DT
Price TargetArticle
UBS€22.68→€25.40buy31.61%UpsideAssigned11/09/26
Leerink Partners€20.86→€22.68buy17.51%UpsideReiterated11/05/26
J.P. Morgan€21.77→€22.68buy17.51%UpsideReiterated11/04/26
Oppenheimer€24.49buy26.91%UpsideReiterated11/03/26
Goldman Sachs€19.05→€21.77buy12.81%UpsideReiterated10/29/26
Barclays€18.14buy-5.99%DownsideReiterated09/21/26
Piper Sandler€15.42buy-20.10%DownsideReiterated07/20/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PVLAPalvella Therapeutics
IRLAIRulya Therapeutics
RZLTRezolute
PTGXProtagonist Therapeutics
CTMXCytomX Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amneal Pharmaceuticals

3 Months
Les Sulewski
Les SulewskiOppenheimer
Success Rate13/18 ratings generated profit
72%
Average Return
+12.62%

Copying Les Sulewski's trades and holding each position for 3 Months would result in 72.22% of your transactions generating a profit, with an average return of +12.62% per trade.

1 Year
Les Sulewski
Les SulewskiOppenheimer
Success Rate18/18 ratings generated profit
100%
Average Return
+67.64%

Copying Les Sulewski's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +67.64% per trade.

2 Years
Les Sulewski
Les SulewskiOppenheimer
Success Rate18/18 ratings generated profit
100%
Average Return
+124.92%

Copying Les Sulewski's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +124.92% per trade.

2DT Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 2DT
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy1111141112
Hold00000
Sell00000
Strong Sell00000
total1111141112

In the current month, 2DT has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2DT average Analyst price target in the past 3 months is 22.53.

2DT Financial Forecast

€-1€-0.5€0€0.5€1Q1 2026Q3 2026Q4 2026
High€0.22
Consensus€0.21
Low€0.19

2DT Earnings Forecast

Next quarter’s earnings estimate for 2DT is EUR 0.21 with a range of EUR 0.19 to EUR 0.22. The previous quarter’s EPS was EUR 0.23. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€644.5M€675.8M€707M€738.3M€769.6MQ1 2026Q3 2026Q4 2026
High€764M
Consensus€748M
Low€724M

2DT Sales Forecast

Next quarter’s sales forecast for 2DT is EUR 747.72M with a range of EUR 724.46M to EUR 764.49M. The previous quarter’s sales results were EUR 769.56M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2DT Stock Forecast FAQ

What is DE:2DT’s average 12-month price target, according to analysts?
Based on analyst ratings, Amneal Pharmaceuticals’s 12-month average price target is €22.53.
What is DE:2DT’s upside potential, based on the analysts’ average price target?
Amneal Pharmaceuticals has 16.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amneal Pharmaceuticals a Buy, Sell or Hold?
Amneal Pharmaceuticals has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Amneal Pharmaceuticals’s share price target?
The average share price target for Amneal Pharmaceuticals is €22.53. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €25.40, and the lowest forecast is €18.14. The average share price target represents a 16.72% increase from the current price of €19.3.
What do analysts say about Amneal Pharmaceuticals?
Amneal Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of Amneal Pharmaceuticals?
To buy shares of DE:2DT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.